Admission blood glucose level and outcome in patients requiring venoarterial extracorporeal membrane oxygenation
Authors:
Open Access
- 4 May 2021
- journal article
- research article
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 110 (9) , 1484-1492
Abstract
Background: Patients with cardiogenic shock or cardiac arrest undergoing venoarterial extracorporeal membrane oxygenation (V-A ECMO) frequently present with blood glucose levels out of normal range. The clinical relevance of such findings in the context of V-A ECMO is unknown. We therefore investigated the prognostic relevance of blood glucose at time of cannulation for V-A ECMO. Methods: We conducted a single-center retrospective registry study. All patients receiving V-A ECMO from October 2010 to January 2020 were included if blood glucose level at time of cannulation were documented. Patients were divided in five groups according to the initial blood glucose level ranging from hypoglycemic (< 80 mg/dl), normoglycemic (80–140 mg/dl), to mild (141-240 mg/dl), moderate (241–400 mg/dl), and severe (> 400 mg/dl) hyperglycemia, respectively. Clinical presentation, arterial blood gas analysis, and survival were compared between the groups. Results: 392 patients met inclusion criteria. Median age was 62 years (51.5–70.0), SAPS II at admission was 54 (43.5–63.0), and 108/392 (27.6%) were female. 131/392 were discharged alive (hospital survival 33.4%). At time of cannulation, survivors had higher pH, hemoglobin, calcium, bicarbonate but lower potassium and lactate levels compared to non-survivors (all p < 0.01). Outcome of patients diagnosed with particularly high (> 400 mg/dl) and low (< 80 mg/dl) blood glucose at time of V-A ECMO cannulation, respectively, was worse compared to patients with normoglycemic, mildly or moderately elevated values (p = 0.02). Glucose was independently associated with poor outcome after adjustment for other predictors of survival and persisted in all investigated subgroups. Conclusion: Arterial blood glucose at time of V-A ECMO cannulation predicts in-hospital survival of patients with cardiac shock or after ECPR. Whether dysglycemia represents a potential therapeutic target requires further evaluation in prospective studies. GraphicalKeywords
Funding Information
- Universitäts-Herzzentrum Freiburg - Bad Krozingen GmbH
This publication has 33 references indexed in Scilit:
- Stress hyperglycemia: an essential survival response!Critical Care, 2013
- Hypo- and Hyperglycemia Predict Outcome in Patients With Left Ventricular Dysfunction After Acute Myocardial Infarction: Data From EPHESUSJournal of Cardiac Failure, 2012
- Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort studyBMJ, 2012
- Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort studyCritical Care, 2010
- Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis*Critical Care Medicine, 2009
- Derangements in blood glucose following initial resuscitation from in-hospital cardiac arrest: A report from the national registry of cardiopulmonary resuscitationResuscitation, 2009
- Intensive versus Conventional Glucose Control in Critically Ill PatientsNew England Journal of Medicine, 2009
- Intensive Insulin Therapy and Pentastarch Resuscitation in Severe SepsisNew England Journal of Medicine, 2008
- ?Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarctionEuropean Heart Journal, 2004
- Glucose, insulin and osmolality changes in rats sustaining different hemorrhage volumesActa Physiologica Scandinavica, 1982